Buddlejasaponin IV, CAS 139523-30-1

Product Description: Buddlejasaponin IV (BS‐IV) exerts anti-inflammatory and cytotoxic effects against cancer cells[1].

Applications: COVID-19-immunoregulation

Formula: C48H78O18

References: [1]Young Sun Hwang, et al. Buddlejasaponin IV induces cell cycle arrest at G2/M phase and apoptosis in immortalized human oral keratinocytes. Phytother Res. 2011 Oct;25(10):1503-10./[2]Jong-Heon Won, et al. Anti-inflammatory effect of buddlejasaponin IV through the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via the NF-kappaB inactivation. Br J Pharmacol. 2006 May;148(2):216-25.

CAS Number: 139523-30-1

Molecular Weight: 943.12

Research Area: Cancer; Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: COX;NO Synthase

• Artikelnummer: MEXHY-125131-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-125131-1
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK